Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02143115 · ClinicalTrials.gov registry record
Comparative Effectiveness of CTC & OC
A clinical trial of Colorectal Cancer, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- 244
- Enrollment target
- 5
- Study locations
NCT02143115: Completed study of Colorectal Cancer, sponsored by Fox Chase Cancer Center.
NCT02143115 is a study of Colorectal Cancer that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 244 participants, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02143115, a study of Colorectal Cancer, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- 244 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this study is to compare the findings of virtual (CT-colonography) with findings of optical colonoscopies to determine if virtual colonoscopy is suitable for colorectal cancer surveillance.
Primary Outcome
To evaluate the test characteristics (sensitivity, specificity, positive and negative predictive value) of CT colonography (CT-C) for detecting colorectal adenomas and cancers in the post-CRC resection surveillance setting, using optical colonoscopy (OC) as the reference standard.
Conditions Studied
Interventions
- PROCEDURE Optical colonoscopy
- RADIATION CT-Colonography
Study Locations (5)
Illinois
- University of Chicago - Chicago
Minnesota
- Mayo Clinic - Rochester
New York
- Memorial Sloan Kettering Cancer Center - New York
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Wisconsin
- University of Wisconsin-Madison - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 244 participants |
| Start Date | 2011-08 |
| Est. Completion | 2016-06 |
What the finished NCT02143115 record still lists
NCT02143115 is an observational study that tracks outcomes without assigning an intervention. The registered 244 participants enrollment target is mid-sized for trials with a published cap, below the 1,544-participant average among 381 other Colorectal Cancer trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Optical colonoscopy is the first listed.
NCT02143115 lists 5 locations in 5 states (Illinois, Minnesota, New York).
Frequently Asked Questions
What is clinical trial NCT02143115 about?
NCT02143115 is a clinical study titled "Comparative Effectiveness of CTC & OC". The goal of this study is to compare the findings of virtual (CT-colonography) with findings of optical colonoscopies to determine if virtual colonoscopy is suitable for colorectal cancer surveillance.
What is the current status of trial NCT02143115?
This trial is currently completed. The enrollment target is 244 participants. The study started on 2011-08. Estimated completion is 2016-06.
What conditions does trial NCT02143115 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT02143115?
The interventions under investigation include: Optical colonoscopy (PROCEDURE), CT-Colonography (RADIATION).
Who is sponsoring clinical trial NCT02143115?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02143115 being conducted?
This trial has 5 study locations across Illinois, Minnesota, New York, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02143115's enrollment target sits among peer trials
244 131st of 381 higher than 251 of 381 other Colorectal Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Colorectal Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02227251 · 244 participants · Phase 2
Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
- NCT04317534 · 244 participants · Phase 2
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm
- NCT04683250 · 244 participants · Phase 1
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities
- NCT04686305 · 244 participants · Phase 1
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia